Metropolitan Life Insurance Company (MetLife)’s National Healthcare NHC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-665	Closed	-$62.8K	–	1373
2024 Q1	$62.8K	Sell	665 -74	-10%	-$7.01K	﹤0.01%	1286
2023 Q4	$68.3K	Hold	739	–	–	﹤0.01%	1280
2023 Q3	$47.3K	Hold	739	–	–	﹤0.01%	1427
2023 Q2	$45.7K	Hold	739	–	–	﹤0.01%	1471
2023 Q1	$42.9K	Hold	739	–	–	﹤0.01%	1477
2022 Q4	$44K	Hold	739	–	–	﹤0.01%	1559
2022 Q3	$46.8K	Hold	739	–	–	﹤0.01%	1503
2022 Q2	$51.7K	Sell	739 -159	-18%	-$11.1K	﹤0.01%	1492
2022 Q1	$63.1K	Sell	898 -2,420	-73%	-$163K	﹤0.01%	1462
2021 Q4	$225K	Hold	3,318	–	–	﹤0.01%	1948
2021 Q3	$232K	Sell	3,318 -678	-17%	-$49.3K	﹤0.01%	1955
2021 Q2	$279K	Buy	3,996 +235	+6%	+$17.1K	﹤0.01%	1912
2021 Q1	$293K	Sell	3,761 -215	-5%	-$15.2K	﹤0.01%	1763
2020 Q4	$264K	Hold	3,976	–	–	﹤0.01%	1752
2020 Q3	$248K	Hold	3,976	–	–	﹤0.01%	1649
2020 Q2	$252K	Hold	3,976	–	–	﹤0.01%	1653
2020 Q1	$285K	Hold	3,976	–	–	0.01%	1380
2019 Q4	$344K	Hold	3,976	–	–	0.01%	1555
2019 Q3	$325K	Hold	3,976	–	–	0.01%	1559
2019 Q2	$323K	Hold	3,976	–	–	0.01%	1572
2019 Q1	$302K	Hold	3,976	–	–	0.01%	1633
2018 Q4	$312K	Hold	3,976	–	–	0.01%	1530
2018 Q3	$300K	Hold	3,976	–	–	0.01%	1720
2018 Q2	$280K	Hold	3,976	–	–	﹤0.01%	1717
2018 Q1	$237K	Hold	3,976	–	–	﹤0.01%	1785
2017 Q4	$242K	Sell	3,976 -3,827	-49%	-$244K	﹤0.01%	1789
2017 Q3	$488K	Hold	7,803	–	–	﹤0.01%	1701
2017 Q2	$547K	Hold	7,803	–	–	﹤0.01%	1625
2017 Q1	$556K	Hold	7,803	–	–	﹤0.01%	1579
2016 Q4	$591K	Hold	7,803	–	–	﹤0.01%	1626
2016 Q3	$515K	Hold	7,803	–	–	﹤0.01%	1688
2016 Q2	$505K	Buy	7,803 +138	+2%	+$8.76K	﹤0.01%	1690
2016 Q1	$478K	Hold	7,665	–	–	﹤0.01%	1596
2015 Q4	$473K	Hold	7,665	–	–	﹤0.01%	1657
2015 Q3	$467K	Hold	7,665	–	–	﹤0.01%	1684
2015 Q2	$498K	Sell	7,665 -349	-4%	-$22.2K	﹤0.01%	1747
2015 Q1	$511K	Sell	8,014 -699	-8%	-$44.4K	﹤0.01%	1546
2014 Q4	$548K	Buy	8,713 +784	+10%	+$47.1K	﹤0.01%	1704
2014 Q3	$440K	Sell	7,929 -171	-2%	-$9.66K	﹤0.01%	1792
2014 Q2	$456K	Sell	8,100 -780	-9%	-$42.5K	﹤0.01%	1898
2014 Q1	$495K	Hold	8,880	–	–	﹤0.01%	1809
2013 Q4	$479K	Hold	8,880	–	–	﹤0.01%	1834
2013 Q3	$420K	Hold	8,880	–	–	﹤0.01%	1867
2013 Q2	$424K	Buy	+8,880	New	+$415K	﹤0.01%	1796

Other funds holding NHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NHC Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of National Healthcare (NHC) in Q2 2024, closing a stake of 665 shares — an estimated $62.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NHC in Q2 2013 and held it in 44 quarters. The position peaked at $591K in Q4 2016. 175 funds tracked by Wall St. Rank hold NHC as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining National Healthcare position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 665 National Healthcare shares in Q2 2024, an estimated $62.8K.
Metropolitan Life Insurance Company (MetLife) first reported a position in National Healthcare in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s National Healthcare position peaked at $591K in Q4 2016.
175 funds tracked by Wall St. Rank held National Healthcare as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.